Carisma Therapeutics shares fall 4.76% after-hours following merger announcement with OrthoCellix.

miércoles, 2 de julio de 2025, 4:19 pm ET1 min de lectura
CARM--
Carisma Therapeutics Inc. declined 4.76% in after-hours trading, following news that Halper Sadeh LLC, an investor rights law firm, is investigating potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders relating to Carisma Therapeutics Inc.'s merger with OrthoCellix.

Carisma Therapeutics shares fall 4.76% after-hours following merger announcement with OrthoCellix.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios